ALDX (ALDX) Stock Price & Analysis
ALDX (ALDX) rose 0.00% to USD 1.48 as of September 8, 2026 at 07:00 UTC, according to Nexqual real-time market data.
ALDX last closed at USD 1.48; the session ranged USD 1.46–1.49 on volume of 486,184 shares. Market capitalization is —, with a 52-week range of USD 1.07–5.93 (NCM). Source: Nexqual, September 8, 2026 at 07:00 UTC.
Key Statistics (as of September 8, 2026 at 07:00 UTC)
| Price | USD 1.48 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 1.48 |
| Open | USD 1.48 |
| Day Range | USD 1.46 – 1.49 |
| 52-Week Range | USD 1.07 – 5.93 |
| Volume | 486,184 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ALDX)
Nexqual's technical model rates ALDX "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 07:00 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 37.36 (neutral) |
| vs SMA50 | Below (USD 1.7) |
| MACD | -0.05 (negative) |
From ALDX's Latest SEC 10-K Filing (filed 2026-02-27)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ARDX | Ardelyx, Inc. | USD 3.78 | ▼ 0.53% |
| ACRS | Aclaris Therapeutics, Inc. | USD 6.17 | ▼ 0.16% |
| AKBA | Akebia Therapeutics, Inc. | USD 0.97 | ▼ 0.54% |
| AFMDQ | Affimed N.V. | USD 0 | ▲ 0% |
| ATRA | Atara Biotherapeutics, Inc. | USD 9.76 | ▲ 3.39% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:00 UTC. This page is informational and not investment advice.